United Therapeutics UTHR
NASDAQ UTHR
$577.33 +35.44 (+6.54%)
As of: Oct 1, 2026 · 10:12 AM EDT

United Therapeutics (UTHR) Cash from Operations (2009 - 2026)

Updated

United Therapeutics (UTHR) reported Cash from Operations of $313.6 million for Q2 2026, up 63.6% from $191.7 million a year earlier but down 32.3% from the prior quarter.

Analysis

United Therapeutics (UTHR) Cash from Operations (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, United Therapeutics' Cash from Operations came in at $1.69 billion, up 22.9% year-over-year; for FY2025, it was $1.56 billion, up 17.6% from FY2024.

  • Cash from Operations has increased for four consecutive years, with a five-year compound annual growth rate of 15.6% (FY2020 to FY2025).
  • By year, Cash from Operations came in at $1.33 billion in FY2024 (+35.7%), $978 million in FY2023 (+21.9%), $802.5 million in FY2022 (+34.2%) and $598.2 million in FY2021 (-20.8%).
  • Five-year quarterly Cash from Operations spans a low of $106.3 million in Q2 2023 and a high of $562.1 million in Q3 2025.
  • Year over year, Cash from Operations has now increased in each of the last four quarters, with growth averaging 31.9% over the last eight quarters.
  • The high point for year-over-year Cash from Operations in five years was Q1 2022 (growth of 221.5%); the low point was Q4 2022 (a decline of 26.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $463.3 million (Q1 2026), $346.2 million (Q4 2025) and $562.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 United Therapeutics 23.13 Bn 12.62 Bn 683.80 Mn 313.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 313.60 Mn
Mar 31, 2026 463.30 Mn
Dec 31, 2025 346.20 Mn
Sep 30, 2025 562.10 Mn
Jun 30, 2025 191.70 Mn
Mar 31, 2025 461.20 Mn
Dec 31, 2024 341.20 Mn
Sep 30, 2024 377.20 Mn
Jun 30, 2024 232.20 Mn
Mar 31, 2024 376.50 Mn
Dec 31, 2023 150.70 Mn
Sep 30, 2023 346.20 Mn
Jun 30, 2023 106.30 Mn
Mar 31, 2023 374.80 Mn
Dec 31, 2022 128.20 Mn
Sep 30, 2022 258.60 Mn
Jun 30, 2022 127.00 Mn
Mar 31, 2022 288.70 Mn
Dec 31, 2021 174.60 Mn
Sep 30, 2021 185.60 Mn
API Access

United Therapeutics Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=UTHR&period=max&api_key=YOUR_API_KEY